Compare AXGN & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXGN | ECPG |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2013 | 1999 |
| Metric | AXGN | ECPG |
|---|---|---|
| Price | $32.74 | $68.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $37.63 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 811.8K | 263.5K |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 287.14 |
| EPS | N/A | ★ 10.91 |
| Revenue | $225,208,000.00 | ★ $1,768,802,000.00 |
| Revenue This Year | $19.81 | $3.63 |
| Revenue Next Year | $16.31 | $4.47 |
| P/E Ratio | ★ N/A | $6.23 |
| Revenue Growth | 20.21 | ★ 34.37 |
| 52 Week Low | $9.22 | $26.45 |
| 52 Week High | $36.00 | $74.58 |
| Indicator | AXGN | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 60.79 |
| Support Level | $30.42 | $54.39 |
| Resistance Level | $34.26 | $74.58 |
| Average True Range (ATR) | 1.40 | 3.35 |
| MACD | 0.28 | -0.38 |
| Stochastic Oscillator | 77.93 | 56.06 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.